Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04405713
Other study ID # early LC for ACC
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 1, 2018
Est. completion date March 25, 2020

Study information

Verified date May 2020
Source Mansoura University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The ideal timing for ELC continues to be debatable in patients with acute calculator cholecystitis (ACC). This study was planned to identify the impact of different ELC timing in ACC on surgical outcomes in terms of safety and efficacy


Description:

This multicentric analysis involved of successive patients with ACC ELC between April 2018 and March 2020. Patients were divided into three groups according to the timing of the surgery: from the onset of symptoms within the first 3 days (group 1), between 4 and 7 days (group 2), and beyond 7 days (group 3). The primary outcome was the incidence of postoperative complications The secondary outcomes were conversion rate, blood loss, operative times, operational difficulty, the cost-benefit relationship, postoperative stay with each treatment line.


Recruitment information / eligibility

Status Completed
Enrollment 900
Est. completion date March 25, 2020
Est. primary completion date March 1, 2020
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

ACC patients who underwent early LC

Exclusion Criteria:

Pregnancy, Acalculous cholecystitis, CBDS, Ascending cholangitis, Pancreatitis, ASA score 4, Patients scheduled for DLC with failed medical treatment.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
from the onset of symptoms within the first 3 days
ELC within 3 days of onset of ACC
: from the onset of symptoms within the 4-7 days
ELC 4-7days of onset of ACC
from the onset of symptoms beyond 7 days
ELC after 7days of onset of ACC

Locations

Country Name City State
Egypt Mohamed Attea Mansoura

Sponsors (1)

Lead Sponsor Collaborator
Mansoura University

Country where clinical trial is conducted

Egypt, 

References & Publications (6)

Brunée L, Hauters P, Closset J, Fromont G, Puia-Negelescu S; Club Coelio. Assessment of the optimal timing for early laparoscopic cholecystectomy in acute cholecystitis: a prospective study of the Club Coelio. Acta Chir Belg. 2019 Oct;119(5):309-315. doi: — View Citation

El Zanati H, Nassar AHM, Zino S, Katbeh T, Ng HJ, Abdellatif A. Gall Bladder Empyema: Early Cholecystectomy during the Index Admission Improves Outcomes. JSLS. 2020 Apr-Jun;24(2). pii: e2020.00015. doi: 10.4293/JSLS.2020.00015. — View Citation

Inoue K, Ueno T, Nishina O, Douchi D, Shima K, Goto S, Takahashi M, Shibata C, Naito H. Optimal timing of cholecystectomy after percutaneous gallbladder drainage for severe cholecystitis. BMC Gastroenterol. 2017 May 31;17(1):71. doi: 10.1186/s12876-017-06 — View Citation

Menahem B, Mulliri A, Fohlen A, Guittet L, Alves A, Lubrano J. Delayed laparoscopic cholecystectomy increases the total hospital stay compared to an early laparoscopic cholecystectomy after acute cholecystitis: an updated meta-analysis of randomized contr — View Citation

Mora-Guzmán I, Di Martino M, Gancedo Quintana A, Martin-Perez E. Laparoscopic Cholecystectomy for Acute Cholecystitis: Is the Surgery Still Safe beyond the 7-Day Barrier? J Gastrointest Surg. 2019 Aug 6. doi: 10.1007/s11605-019-04335-5. [Epub ahead of pri — View Citation

Onoe S, Kaneoka Y, Maeda A, Takayama Y, Fukami Y. Feasibility of laparoscopic cholecystectomy for acute cholecystitis beyond 72 h of symptom onset. Updates Surg. 2016 Dec;68(4):377-383. Epub 2016 Oct 26. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary the incidence of postoperative morbidity the incidence of postoperative morbidity during the 30th day of postoperative procedure 30 DAYS
Secondary conversion rate conversion rate to open cholecystectomy INTRAOPERATIVE
Secondary blood loss blood loss intraoperative
Secondary hospital stay overall hospital stay 30 days
See also
  Status Clinical Trial Phase
Completed NCT04156711 - Remote Ischemic Preconditioning in Patients Undergoing Acute Minor Abdominal Surgery N/A
Recruiting NCT02130245 - Acute Cholecystitis: Early Versus Delayed Laparoscopic Cholecystectomy; Randomized Prospective Study N/A
Completed NCT01942356 - Evaluation of Closed-loop TIVA Propofol, Sufentanil and Ketamine Guided by BIS Monitor N/A
Completed NCT04995380 - Validation and Comparison of Scores for Prediction of RIsk for Post-operative Major Morbidity After Cholecystectomy in Acute Calculous Cholecystitis (SPRIMACC)
Completed NCT03999645 - Is it Safe to do Laparoscopic Cholecystectomy for Acute Cholecystitis up to Seven Days? N/A
Completed NCT03296280 - Evaluation of Implementation of a National Point-of-Care Ultrasound Training Program
Completed NCT03002051 - EUS-guided Transenteric Drainage With a Novel Lumen-apposing Metal Stent N/A
Completed NCT00447304 - Acute Cholecystitis - Early Laparoscopic Surgery Versus Antibiotic Therapy and Delayed Elective Cholecystectomy Phase 3
Completed NCT04346550 - Comparison of Morbidity After Laparoscopic Cholecystectomy for Acutely Inflamed Gall Bladder With and Without Drain N/A
Active, not recruiting NCT04197908 - EUS-guided Gallbladder Drainage Instead of Laparoscopic Cholecystectomy for Acute Cholecystitis. A Feasibility Study. N/A
Completed NCT02027402 - Effects of Drainage in Laparoscopic Cholecystectomy N/A
Not yet recruiting NCT01706068 - Transient ECG Changes in Patients With Acute Biliary Disease N/A
Enrolling by invitation NCT04633512 - Safety and Feasibility of ActivSightTM in Human N/A
Completed NCT04672902 - Treatment of Mirizzi Syndrome
Completed NCT03122054 - Early Versus Delayed Cholecystectomy N/A
Recruiting NCT05732480 - Influence of Gut Microbiome in Gallstone Disease
Completed NCT04308265 - Scoring System in Acute Calculous Cholecystitis
Not yet recruiting NCT06287112 - Prevention of Acute Cholecystitis With ETGBD N/A
Recruiting NCT05709548 - Use of Indocyanine Green in Acute Cholecystitis Phase 4
Not yet recruiting NCT06459323 - the Outcomes of Laparoscopic Cholecystectomy for Acute Cholecystitis Within and Beyond the First 72 Hours, Does it Differ?! N/A

External Links